We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The company said last month it would partner with US-based Refana Inc to make a potential COVID-19 vaccine, in a collaboration that expects to have over 40 million doses available early next year.